Editorials

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia

Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2020.249060